Article
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
6 Feb 2024
Abstract excerpt
The current SARS-CoV-2 variants strikingly evade all authorized monoclonal antibodies and threaten the efficacy of serum-neutralizing activity elicited by vaccination or prior infection, urging the need to develop antivirals against SARS-CoV-2 and related sarbecoviruses. Here, we identified both potent and broadly neutralizing antibodies from a five-dose vaccinated donor who exhibited cross-reactive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
